Inovio Pharmaceuticals, Inc. (INO)
1.19
+0.03
(+2.59%)
USD |
NASDAQ |
Apr 17, 16:00
1.20
+0.01
(+0.84%)
After-Hours: 20:00
Inovio Pharmaceuticals SG&A Expense (Quarterly) : 7.215M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 48.23M |
| ADMA Biologics, Inc. | 24.64M |
| Vaxart, Inc. | 3.666M |
| Capricor Therapeutics, Inc. | 6.025M |
| Allogene Therapeutics, Inc. | 13.77M |